AGIOS PHARMACEUTICALS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Agios Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2023.
  • Agios Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $11.6M, a 1.47% decline year-over-year.
  • Agios Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $43.7M, a 1.82% decline year-over-year.
  • Agios Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $44.8M, a 9.19% decline from 2022.
  • Agios Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $49.3M, a 7.87% decline from 2021.
  • Agios Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $53.5M, a 13.1% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $44.8M -$4.53M -9.19% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $49.3M -$4.21M -7.87% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $53.5M -$8.09M -13.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $61.6M +$3.55M +6.12% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $58.1M -$15.3M -20.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $73.4M +$25.5M +53.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $47.8M +$5.72M +13.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-19
2016 $42.1M +$10.1M +31.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-14
2015 $32M +$20.5M +178% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-14
2014 $11.5M +$8.48M +280% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-16
2013 $3.03M +$2.29M +308% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 $742K +$371K +100% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-24
2011 $371K Jan 1, 2011 Dec 31, 2011 10-K 2014-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.